ICON Medical Imaging was founded as Beacon Bioscience in 2000. In July of 2004 Beacon Bioscience, Inc. and ICON plc entered into a partnership through which ICON plc acquired 70% of Beacon. This partnership deepens our resources and strengthens our global footprint. As part of a 6,000 person organization with 71 offices in 37 countries, our medical imaging services can truly support your study anywhere in the world, locally, and centrally.
To further represent the strength of this relationship, Beacon has changed its name to ICON Medical Imaging as of April 2007. ICON Medical Imaging continues to operate as an independent division of ICON plc, providing specialized imaging services to pharmaceutical, biotech, medical device companies and CROs, to assure the success of your imaging-based trial endpoints.